Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 31% ± 8% | |
lung | 10 studies | 26% ± 9% | |
intestine | 10 studies | 29% ± 14% | |
eye | 7 studies | 32% ± 13% | |
kidney | 5 studies | 24% ± 6% | |
lymph node | 5 studies | 28% ± 4% | |
brain | 5 studies | 26% ± 6% | |
pancreas | 4 studies | 33% ± 15% | |
bone marrow | 4 studies | 26% ± 8% | |
breast | 4 studies | 19% ± 1% | |
liver | 4 studies | 35% ± 23% | |
placenta | 3 studies | 21% ± 4% | |
uterus | 3 studies | 30% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6518.89 | 1445 / 1445 | 100% | 80.20 | 183 / 183 |
intestine | 100% | 9271.25 | 966 / 966 | 100% | 85.94 | 527 / 527 |
ovary | 100% | 7540.44 | 180 / 180 | 100% | 75.46 | 430 / 430 |
pancreas | 100% | 4990.77 | 328 / 328 | 100% | 60.31 | 178 / 178 |
prostate | 100% | 5780.69 | 245 / 245 | 100% | 70.31 | 502 / 502 |
stomach | 100% | 5619.62 | 359 / 359 | 100% | 81.04 | 286 / 286 |
uterus | 100% | 6898.32 | 170 / 170 | 100% | 77.87 | 459 / 459 |
breast | 100% | 6764.71 | 459 / 459 | 100% | 81.20 | 1117 / 1118 |
brain | 100% | 4890.37 | 2638 / 2642 | 100% | 74.24 | 705 / 705 |
lung | 100% | 5570.34 | 577 / 578 | 100% | 74.90 | 1155 / 1155 |
bladder | 100% | 7831.81 | 21 / 21 | 100% | 76.53 | 503 / 504 |
kidney | 100% | 3954.81 | 89 / 89 | 100% | 57.04 | 897 / 901 |
thymus | 100% | 5084.45 | 652 / 653 | 100% | 53.62 | 602 / 605 |
liver | 100% | 2618.00 | 226 / 226 | 99% | 37.45 | 403 / 406 |
adrenal gland | 100% | 7189.10 | 258 / 258 | 98% | 48.81 | 226 / 230 |
skin | 100% | 7466.82 | 1809 / 1809 | 98% | 71.56 | 463 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 121.63 | 29 / 29 |
muscle | 100% | 10527.72 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6593.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 76.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.78 | 1 / 1 |
blood vessel | 100% | 5497.92 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 6641.33 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 6563.35 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 48.92 | 78 / 80 |
peripheral blood | 89% | 5664.50 | 829 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007283 | Biological process | spermatogenesis |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0000165 | Biological process | MAPK cascade |
GO_0060252 | Biological process | positive regulation of glial cell proliferation |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0051301 | Biological process | cell division |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0046822 | Biological process | regulation of nucleocytoplasmic transport |
GO_0030182 | Biological process | neuron differentiation |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0001824 | Biological process | blastocyst development |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005730 | Cellular component | nucleolus |
GO_0098793 | Cellular component | presynapse |
GO_0030496 | Cellular component | midbody |
GO_0043197 | Cellular component | dendritic spine |
GO_0005739 | Cellular component | mitochondrion |
GO_0016607 | Cellular component | nuclear speck |
GO_0000776 | Cellular component | kinetochore |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0072357 | Cellular component | PTW/PP1 phosphatase complex |
GO_0032154 | Cellular component | cleavage furrow |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0004721 | Molecular function | phosphoprotein phosphatase activity |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005521 | Molecular function | lamin binding |
GO_0008157 | Molecular function | protein phosphatase 1 binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
GO_0016791 | Molecular function | phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP1CC |
Protein name | protein-serine/threonine phosphatase (EC 3.1.3.16) Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit) Serine/threonine-protein phosphatase (EC 3.1.3.16) |
Synonyms | |
Description | FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Dephosphorylates RPS6KB1. Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective . . |
Accessions | F8VR82 F8VYE8 ENST00000550261.5 P36873 F8W0W8 ENST00000551676.5 ENST00000551582.1 ENST00000335007.10 [P36873-1] F8W0V8 ENST00000546933.5 ENST00000340766.9 [P36873-2] ENST00000550991.5 Q9UPN1 F8W1A0 ENST00000620030.1 A0A087WYY5 |